neurokinin a (4-10), beta-ala(8)- has been researched along with phenyl acetate in 1 studies
| Studies (neurokinin a (4-10), beta-ala(8)-) | Trials (neurokinin a (4-10), beta-ala(8)-) | Recent Studies (post-2010) (neurokinin a (4-10), beta-ala(8)-) | Studies (phenyl acetate) | Trials (phenyl acetate) | Recent Studies (post-2010) (phenyl acetate) |
|---|---|---|---|---|---|
| 71 | 0 | 2 | 41,232 | 1,558 | 8,330 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Couture, R; Deschamps, K | 1 |
1 other study(ies) available for neurokinin a (4-10), beta-ala(8)- and phenyl acetate
| Article | Year |
|---|---|
The ventral tegmental area as a putative target for tachykinins in cardiovascular regulation.
Topics: Acetates; Adrenergic beta-Antagonists; Animals; Atenolol; Behavior, Animal; Benzamides; Benzazepines; Blood Pressure; Dopamine D2 Receptor Antagonists; Glutamic Acid; Heart Rate; Indoles; Male; Neurokinin A; Neurokinin-1 Receptor Antagonists; Peptide Fragments; Piperidines; Quinolines; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Neurokinin-1; Receptors, Neurokinin-2; Receptors, Neurokinin-3; Substance P; Ventral Tegmental Area | 2005 |